Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website http://www.journalmc.org

Case Report

Volume 9, Number 9, September 2018, pages 320-322

Pembrolizumab-Induced Hepatitis and Pancreatitis in a Patient With Stage IV Non-Small Cell Lung Cancer

Figures

Figure 1.
Figure 1. Liver function trends during hospitalization in relation of pembrolizumab infusion.
Figure 2.
Figure 2. Liver function trends during hospitalization in relation of pembrolizumab infusion.

Table

Table 1. Pertinent Labs of the Patient During Hospitalizations
 
Lipase (IU/L)906/588/746
ANANegative
ANCANegative
F-actin AbNegative
IgG4Normal
U-ToxAmphetamine cocaine opiates
PTT (s)34.2
PT (s)13/13.2/14.3
INR1.17/1.16/1.26
Acetaminophen level (#xb5;g/mL) 1
ETOH level (mg/dL) 10
Hepatitis panelNegative
Lactate (mg/dL)1.17
CD4 count485
Viral load 20
GGT (mg/dL)650
Ammonia (#xb5;mol/L)33
Stool cultureNo growth